BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdallah OM, Abdel-Megied AM, Gouda AS. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study. Biomed Chromatogr 2018;32:e4186. [PMID: 29314090 DOI: 10.1002/bmc.4186] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Ferrari D, Bagaglio S, Raso M, Galli L, Premaschi S, Messina E, Morsica G, Locatelli M, Uberti-Foppa C, Hasson H. A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1120:1-7. [PMID: 31055190 DOI: 10.1016/j.jchromb.2019.04.048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Bartlett MG. Editorial. Biomed Chromatogr 2020;34:e4764. [PMID: 31884691 DOI: 10.1002/bmc.4764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhong Z, Li G, Guo L, Yao J, Liu Z, Deng J. Solid-phase extraction based on amino-functionalized graphene oxide nanocomposites for analysis of short-chain perfluorinated alkyl acids in human serum by ion chromatography mass spectrometry. Biomedical Chromatography 2018;32:e4223. [DOI: 10.1002/bmc.4223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Essam HM, Morsi AM, El-Zeiny MB. Multivariable Manipulation of Spectrophotometric Data with Genetic Algorithm Selection for Novel Quantitative Resolution of Five Antiviral Drugs in Their Pharmaceutical Products. J AOAC Int 2021;104:571-8. [PMID: 33492390 DOI: 10.1093/jaoacint/qsaa176] [Reference Citation Analysis]
5 Jouyban A, Farajzadeh MA, Khodadadeian F, Khoubnasabjafari M, Afshar Mogaddam MR. Development of a deep eutectic solvent-based ultrasound-assisted homogenous liquid-liquid microextraction method for simultaneous extraction of daclatasvir and sofosbuvir from urine samples. J Pharm Biomed Anal 2021;204:114254. [PMID: 34256327 DOI: 10.1016/j.jpba.2021.114254] [Reference Citation Analysis]
6 Abo-Zeid MN, El-Gizawy SM, Atia NN, El-Shaboury SR. Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis. J Pharm Biomed Anal 2018;156:358-65. [PMID: 29753282 DOI: 10.1016/j.jpba.2018.04.049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Abdel-lateef MA, Omar MA, Ali R, Derayea SM. Micellar spectrofluorimetric protocol for the innovative determination of HCV antiviral (daclatasvir) with enhanced sensitivity: Application to human plasma and stability study. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2019;206:57-64. [DOI: 10.1016/j.saa.2018.07.101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
8 Al-Tannak NF, Hemdan A, Eissa MS. Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring. Int J Anal Chem 2018;2018:6535816. [PMID: 30420886 DOI: 10.1155/2018/6535816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Aboras SI, Abdine HH, Ragab MAA, Korany MA. A Review on Analytical Strategies for the Assessment of Recently Approved Direct Acting Antiviral Drugs. Crit Rev Anal Chem 2021;:1-23. [PMID: 34138669 DOI: 10.1080/10408347.2021.1923456] [Reference Citation Analysis]
10 Niessen W. Tandem mass spectrometry of small-molecule antiviral drugs: 2. hepatitis-related antivirals. International Journal of Mass Spectrometry 2020;455:116371. [DOI: 10.1016/j.ijms.2020.116371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Abdallah IA, Hammad SF, Bedair A, Mansour FR. A green homogeneous liquid-liquid microextraction method for spectrophotometric determination of daclatasvir in human plasma. Sustainable Chemistry and Pharmacy 2021;22:100498. [DOI: 10.1016/j.scp.2021.100498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Baker MM, Hammad SF, Belal TS. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies. Drug Dev Ind Pharm 2019;45:1111-9. [PMID: 30929537 DOI: 10.1080/03639045.2019.1593444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
13 Aydoğmuş Z, Asfoor A. Electroanalytical Methods for Determination of Antiviral Drugs in Pharmaceutical Formulation and Biological Fluids: A Review. Chinese Journal of Analytical Chemistry 2022. [DOI: 10.1016/j.cjac.2022.100063] [Reference Citation Analysis]
14 Hefnawy M, Hammad S, Kadi A, Alsaif N, Mohammed M, Al-hossaini A, Bin Jardan Y, Attwa M, Abou-el-alamin M. Effective quantification of ravidasvir (an NS5A inhibitor) and sofosbuvir in rat plasma by validated LC-MS/MS method and its application to pharmacokinetic study. Arabian Journal of Chemistry 2020;13:8160-71. [DOI: 10.1016/j.arabjc.2020.09.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 El-Nabarawi M, Nafady M, Elmenshawe S, Elkarmalawy M, Teaima M. Liver Targeting of Daclatasvir via Tailoring Sterically Stabilized Bilosomes: Fabrication, Comparative In Vitro/In Vivo Appraisal and Biodistribution Studies. Int J Nanomedicine 2021;16:6413-26. [PMID: 34556987 DOI: 10.2147/IJN.S319255] [Reference Citation Analysis]
16 Keyvan K, Sohrabi MR, Motiee F. Improved spectral resolution for the rapid simultaneous spectrophotometric determination of sofosbuvir and daclatasvir as anti hepatitis C virus drugs in pharmaceutical formulation and biological fluid using continuous wavelet and derivative transform. Spectrochim Acta A Mol Biomol Spectrosc 2021;251:119429. [PMID: 33477087 DOI: 10.1016/j.saa.2021.119429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
17 van Seyen M, de Graaff Teulen MJ, van Erp NP, Burger DM. Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS. Journal of Chromatography B 2019;1110-1111:15-24. [DOI: 10.1016/j.jchromb.2019.01.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
18 Saleh MA, Mohamed MA, Shahat A, Allam NK. Sensitive Determination of SARS-COV-2 and the Anti-hepatitis C Virus Agent Velpatasvir Enabled by Novel Metal-Organic Frameworks. ACS Omega 2021;6:26791-8. [PMID: 34661033 DOI: 10.1021/acsomega.1c04525] [Reference Citation Analysis]
19 Youssef AA, Magdy N, Hussein LA, El-Kosasy AM. Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt. J Chromatogr Sci 2019;57:636-43. [PMID: 31063182 DOI: 10.1093/chromsci/bmz038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Atia NN, El-Shaboury SR, El-Gizawy SM, Abo-Zeid MN. Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits. J Pharm Biomed Anal 2018;158:88-93. [PMID: 29864695 DOI: 10.1016/j.jpba.2018.05.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Gad M, Hassan SA, Zaazaa HE, Amer SM. Multivariate Development and Optimization of Stability Indicating Method for Determination of Daclatasvir in Presence of Potential Degradation Products. Chromatographia 2019;82:1641-52. [DOI: 10.1007/s10337-019-03793-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]